BioMarin Pharmaceuticals
BMRN
BMRN
393 hedge funds and large institutions have $16.8B invested in BioMarin Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 149 increasing their positions, 139 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
13% less funds holding in top 10
Funds holding in top 10: 16 → 14 (-2)
22% less capital invested
Capital invested by funds: $21.6B → $16.8B (-$4.83B)
Holders
393
Holding in Top 10
14
Calls
$211M
Puts
$228M
Top Buyers
| 1 | +$288M | |
| 2 | +$257M | |
| 3 | +$140M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$51.1M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$46M |
Top Sellers
| 1 | -$113M | |
| 2 | -$73.5M | |
| 3 | -$66.1M | |
| 4 |
BRC
Blue Ridge Capital
New York
|
-$61.1M |
| 5 |
Jennison Associates
New York
|
-$57.6M |